Strategic Collaboration Ingenza actively pursues partnerships to accelerate from lab to scalable production, notably the Apr 2026 collaboration with AB BioTechnologies, presenting a compelling entry point for joint development and manufacturing opportunities.

IND Readiness The inGenius platform supports IND readiness with efficient, compliant bioprocesses, offering a strong value proposition for CROs and biopharma clients seeking early-stage development and scalable manufacturing pathways.

Boutique CRDMO As a boutique, employee-owned CRDMO, Ingenza emphasizes personalized service, flexible engagement, and rapid responsiveness, which can be positioned as a differentiator when selling to mid-sized biotech firms seeking bespoke solutions.

Expansion & Capacity Recent facility expansion in Edinburgh and a funded plan to double capacity signal growing demand and capacity for larger projects, enabling sales leads in scale-up, process development, and high-throughput screening services.

Technology Edge Proprietary tools like codABLE gene optimization and integrated process development create a compelling technology moat for customers needing accelerated timelines, predictable results, and scalable biomanufacturing workflows.